| Subjects |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Anti-Dumping and International Trade |
|
Subjects - Anti-Dumping and International Trade
Dumping takes place when a company sells goods at a lower price in the foreign market then the price it charges in its domestic market. This is an unfair trade practice which can have a distorted effect on international trade. There are two fundamental parameters used for determination of dumpi According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ng, namely, the normal value and the export price. Both these elements have to be compared at the same level of trade, generally at ex-factory level, for assessment of dumping.
The normal value is generally the price of the product at issue, in the ordinary course of trade, when destined for co ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in sumption in the exporting country market. Export price of goods means the price at which the goods are sold to importing country. It is generally the cost, insurance and freight (CIF) value minus the adjustments account of ocean freight, insurance, commission etc. so as to arrive at the value o lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ex-factory level. There is nothing inherently illegal about dumping as long as it does not cause material injury to domestic industries. However, when dumping causes or threatens to cause material injury to the domestic industry, the anti-dumping authorities initiate necessary action for inves here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe igations and subsequent imposition of anti-dumping duties. Under Article VI of GATT 1994, and the Anti-Dumping Agreement, WTO Members can impose anti-dumping measures, if, after investigation in accordance with the Agreement, a determination is made (a) that dumping is occurring, (b) that the d d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro mestic industry producing the like product in the importing country is suffering material injury, and (c) that there is a causal link between the two. However, in order to take anti-dumping action, anti-dumping authorities have to show that dumping is taking place, calculate the extent of dumpi ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc g, and show that dumping is causing injury or threatening to do so to the domestic industries. Therefore, the agreement clearly lays down the principle that anti-dumping duties on dumped imports cannot be levied solely on the ground that a product is being sold at a lower price to the importing easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi country. They can be levied only if it is established, that the dumping is causing material injury to that industry. Broadly, injury may be analyzed in terms of the volume effect and price effect of the dumped imports. The parameters by which injury to the domestic industry is to be assessed i nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically the anti-dumping proceedings are such economic indicators having a bearing upon the state of industry as the magnitude of dumping, and the decline in sales, selling price, profits, market share, production, utilization of capacity etc Anti-dumping action involves charging extra import duty i.e and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ anti-dumping duty on the particular product that is being exported from a particular country in order to bring its price closer to the domestic price or to remove the injury to the domestic industry in importing country. Under the GATT provisions, anti-dumping duties cannot exceed dumping marg ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi n. However, it is suggested to impose a lesser duty, which is adequate to remove the injury caused to domestic industry. Under Indian laws, the authorities are obliged to restrict the anti-dumping duty to lower of the two i.e. dumping margin and injury margin. Any exporter whose margin of dumpi ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a g is less than 2% of the export price shall be excluded from the purview of anti-dumping duties even if the existence of dumping, injury as well as the causal link is established Extensive investigation against any country is required to be terminated if the volume of the dumped imports, actual dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod or potential, from a particular country accounts for less than 3% of the total imports provided the cumulative imports from all those countries who individually account for less than 3%, are not more than 7%. Furthermore, it is imperative to prove that the dumping has caused injury to the domes cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ic industry. Disputes in the anti-dumping area are subject to binding dispute settlement before the Dispute Settlement Body of the WTO, in accordance with the provisions of the Dispute Settlement Understanding ("DSU") (Article 17). Members may challenge the imposition of anti-dumping measures, tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen in some cases may challenge the imposition of preliminary anti-dumping measures, and can raise all issues of compliance with the requirements of the Agreement, before a panel established under the DSU. Apart from dumping, some of the countries also resort to subsidization of their exports to o t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel her countries. Export subsidies, under the WTO agreement, are treated as unfair trade practice and such subsidies are actionable by way of levy of anti-subsidy countervailing duty. However such duties can be levied only if preliminary investigations have established that subsidization is actuall ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust taking place. The Agreement on Safeguards authorizes importing countries to restrict imports for temporary periods, if after investigation it has been established that imports are causing serious injury to the domestic industry. Safeguard measures include increasing tariffs over bound rates or y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products imposing quantitative restrictions. Anti-dumping & Anti-subsidy cases in India The countries prominently figuring in the anti-dumping investigations by India are China PR, EU, Chinese Taipei, Korea RP, Japan, USA, Singapore, Indonesia, Thailand, Russia etc. Investigations were carried i . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de 188 cases from various sectors like Chemicals and Petrochemicals, Pharmaceuticals, Textiles, Steel and other materials, Consumer goods etc. involving 35 countries/ territories. EU, US, Canada and South Africa account for almost 60% of anti-dumping cases initiated against Indian exports. India elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip exports are also facing number of anti-subsidy cases by other member countries of WTO. EU, USA and South Africa account for 83% of the anti-subsidy cases initiated against Indian exports. For reading other articles, please visit at: http://www.tradeindia.com/newsletters/newsletter_archives.htm tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Make Money From Your Lack Of DIY Skills How to Develop a Bigger and Better Business Strategy 3 Simple Steps to Fantastic Testimonials
|